2015
DOI: 10.1016/j.jpag.2014.12.011
|View full text |Cite
|
Sign up to set email alerts
|

Effectiveness of the Association N-Palmitoylethanolamine and Transpolydatin in the Treatment of Primary Dysmenorrhea

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
29
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(30 citation statements)
references
References 24 publications
1
29
0
Order By: Relevance
“…However, there are still more to explore behind these experiment data. Firstly, although plenty of clinical studies have been performed to evaluate the beneficial effect of polydatin on human [ 60 , 61 ], as far as we know, a few of them are focused on diabetes. Since several basic studies, including the present study, have investigated the therapeutic effect of polydatin on diabetes complication [ 62 , 63 ]; it is of great necessity to perform clinical investigation.…”
Section: Discussionmentioning
confidence: 99%
“…However, there are still more to explore behind these experiment data. Firstly, although plenty of clinical studies have been performed to evaluate the beneficial effect of polydatin on human [ 60 , 61 ], as far as we know, a few of them are focused on diabetes. Since several basic studies, including the present study, have investigated the therapeutic effect of polydatin on diabetes complication [ 62 , 63 ]; it is of great necessity to perform clinical investigation.…”
Section: Discussionmentioning
confidence: 99%
“…This study showed that the combination PEA-PLD represents a significant additional treatment to TENS, as it is able to down-regulate the hyperactivity of mast cells that are responsible for the proliferation and propagation of the vestibular pain fibers and of hyperalgesia and allodynia [101]. The combination of PEA and PLD appears to be a promising adjunctive therapy in the treatment of primary dysmenorrhoea in adolescents and young women [102]. In a more recent study, it was shown that the m-(PEA/PLD) compound was able to reduce the inflammatory pain that is induced by the injection of carrageenan in the hind paws of rats.…”
Section: Pea Synergy With Natural Molecules With Antioxidant Propmentioning
confidence: 99%
“…These are highest during the first two days of menstruation, which coincides with the period of greatest pain. MC degranulation may play a role in peripheral nerve sensitization and pelvic pain [ 74 ], which, if recurrent, may cause central sensitization and increase susceptibility to other chronic pain conditions. As PEA down-regulates COX-2 and prevents the recruitment and activation of MCs, it would be expected to mitigate the hyperinflammatory state present in dysmenorrhea.…”
Section: Pea and Painmentioning
confidence: 99%
“…As PEA down-regulates COX-2 and prevents the recruitment and activation of MCs, it would be expected to mitigate the hyperinflammatory state present in dysmenorrhea. In one trial, the combined administration of PEA-transpolydatin (400 mg + 40 mg) for 10 days to young women with primary dysmenorrhea significantly reduced pelvic pain compared to placebo [ 74 ].…”
Section: Pea and Painmentioning
confidence: 99%